Over the current book year the total revenue from the company in Foster City will be 24.79 billion USD (consensus estimates). This is slightly more than 2020's revenue of 24.69 billion USD.
The analysts expect for 2021 a net profit of 9.02 billion USD. The majority of the analysts expects for this year a profit per share of 7.17 USD. Based on this the price/earnings-ratio is 8.92.
Based on the current number of outstanding shares Gilead Sciences 's market capitalization 81.01 billion USD. The Gilead Sciences stock was the past 12 months quite unstable. Since last March the stock is 10 percent lower. This year the stock price moved between 57 and 86 dollar.
Click here for dividend Gilead Sciences. On Thursday the stock closed at 63.99 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.